1-5 of 5
S. J Forman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes for Unrelated Donor Hematopoietic Cell Transplantation (URD-HCT) for Patients with Acute Lymphoblastic Leukemia (ALL) Using Fractionated Total Body Irradiation (FTBI) and Etoposide (VP16).

Margaret O’Donnell, P Parker, A Dagis, ML Slovak, D Snyder, A Stein, R. Spielberger, A Pawlowska, J Rosenthal, J Palmer, N. Kogut, S. J Forman
Journal: Blood
Blood (2008) 112 (11): 3286.
https://doi.org/10.1182/blood.V112.11.3286.3286
Published: 2008
Journal Articles

Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation for High-Risk Acute Lymphoblastic Leukemia: A Potential Therapeutic Approach for High Risk ALL Patients Not Eligible for Full Intensity Transplantation

A. Stein, J Palmer, M O’Donnell, N. Kogut, R Spielberger, ML Slovak, NC Tsai, S. J Forman
Journal: Blood
Blood (2008) 112 (11): 4321.
https://doi.org/10.1182/blood.V112.11.4321.4321
Published: 2008
Journal Articles

Clinical Outcomes of Patients with T Cell NHL Undergoing Allogeneic Stem Cell Transplant.

Jasmine Zain, MD, J. Palmer, Ph.D, N. Tsai, L. Popplewell, M.D., A. Nadamanee, M.D., A. Krishnan, M.D., R. Nakamura, M.D., R. Rodriguez, M.D., S. J. Forman, M.D., M. Kirschbaum, M.D.
Journal: Blood
Blood (2006) 108 (11): 3026.
https://doi.org/10.1182/blood.V108.11.3026.3026
Published: 2006
Journal Articles

Peripheral Blood Stem Cells vs Bone Marrow for Matched Sibling Transplant in AML and ALL in First Remission.

Mark Kirschbaum, MD, M. O’Donnell, MD, R. Spielberger, MD, R. Bhatia, MD, V. Pullarkat, MD, A. S. Stein, MD, N. Kogut, MD, E. Bolotin, MD, K. Chang, MD, J. Land, RN, C. Sarkodee-Adoo, MD, D. Snyder, MD, S. J. Forman, MD.
Journal: Blood
Blood (2004) 104 (11): 3321.
https://doi.org/10.1182/blood.V104.11.3321.3321
Published: 2004
Journal Articles

Analysis of Long Term Outcome in Autologous Stem Cell Transplant (ASCT) for Acute Myelogenous Leukemia (AML) in First Remission (CR1) - a 15 Year Experience.

Anthony Selwyn Stein, MD, M. O’Donnell, MD, P. Parker, MD, R. Spielberger, MD, A. Nademanee, MD, R. Bhatia, MD, D. S. Snyder, MD, M. Kirschbaum, MD, V. Pullarkat, MD, N. Kogut, MD, E. Bolotin, MD, K. Chang, MD, C. Sarkodee-Adoo, MD, M. Slovak, MD, N. Vora, MD, J. Land, RN, A. Dagis, J. Palmer, S. J. Forman, MD
Journal: Blood
Blood (2004) 104 (11): 1870.
https://doi.org/10.1182/blood.V104.11.1870.1870
Published: 2004